Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Azacitidine in Treating Patients With Chronic Myelomonocytic Leukemia

This study has been completed.
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: November 4, 2010
Last updated: August 23, 2013
Last verified: November 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2013
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)